Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis

被引:18
|
作者
Wu, Liucheng [1 ]
Ge, Lianying [2 ]
Qin, Yuzhou [1 ]
Huang, Mingwei [1 ]
Chen, Jiansi [1 ]
Yang, Yang [1 ]
Zhong, Jianhong [3 ]
机构
[1] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gastrointestinal Surg, Nanning 530021, Guangxi Autonom, Peoples R China
[2] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Endoscopy, 71 Hedi Rd, Nanning 530021, Guangxi Autonom, Peoples R China
[3] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobilliary Surg, Nanning 530021, Guangxi Autonom, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2019年 / 11卷
基金
中国国家自然科学基金;
关键词
gastric cancer; surgery; postoperative morbidity; propensity score; neoadjuvant chemotherapy; PERIOPERATIVE CHEMOTHERAPY; SURGICAL COMPLICATIONS; PHASE-II; ADENOCARCINOMA; CLASSIFICATION; SARCOPENIA; STOMACH; TRIAL;
D O I
10.2147/CMAR.S203880
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cohort studies have shown that neoadjuvant chemotherapy (NAC) is not associated with increased risk of postoperative complications and mortality as compared to upfront surgery (SURG). Objective: The aim of this study was to compare postoperative morbidity and mortality after NAC with SURG. Patients and methods: Patients who underwent gastrectomy with D2 lymphadenectomy for advanced gastric cancer (GC) between 2010 and 2017 were selected. The impact of neoadjuvant chemotherapy on surgical safety was investigated by using propensity score matching. Results: Three hundred and seventy-seven patients were included. After propensity score matching, 86 patients in each group were matched. The percentage of patients with one or more complications was 10.5% in NAC group and 15.1% in SURG group (P=0.361), there was no mortality developed in either group. The total blood loss was significantly more in the NAC group than that in the SURG group (320.79 vs 243.37 ml, P<0.04). In univariate and multivariate of the matched cohort, sex, age (<70), BMI (<24), ASA grade, surgical procedure (open vs laparoscopy), gastrectomy extent, cTNM and Charlson index comorbidity were not associated with postoperative complications (all P>0.05). Conclusion: This study showed that postoperative morbidity and mortality were similar for NAC group and SURG group.
引用
收藏
页码:6011 / 6018
页数:8
相关论文
共 50 条
  • [41] Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis
    Zhu, Youqi
    Chen, Jiuzhou
    Sun, Xueqing
    Lou, Yufei
    Fang, Miao
    Zhou, Fengjuan
    Zhang, Lei
    Xin, Yong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis
    Chen, Xing
    Liu, Geng
    Wang, Kaiqiang
    Chen, Guodong
    Sun, Jinjin
    ONCOTARGET, 2017, 8 (29) : 47831 - 47840
  • [43] Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis
    De Felice, Francesca
    Musio, Daniela
    Iafrate, Franco
    Caponnetto, Salvatore
    Picone, Vincenzo
    D'ambrosio, Giancarlo
    Magliocca, Fabio Massimo
    Tozzi, Francesca
    De Toma, Giorgio
    Tombolini, Vincenzo
    Cortesi, Enrico
    ANTICANCER RESEARCH, 2022, 42 (02) : 991 - 1000
  • [44] Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial
    Claassen, Y. H. M.
    Hartgrink, H. H.
    Dikken, J. L.
    de Steur, W. O.
    van Sandick, J. W.
    van Grieken, N. C. T.
    Cats, A.
    Trip, A. K.
    Jansen, E. P. M.
    Kranenbarg, W. M. Meershoek-Klein
    Braak, J. P. B. M.
    Putter, H.
    Henegouwen, M. I. van Berge
    Verheij, M.
    van de Velde, C. J. H.
    EJSO, 2018, 44 (05): : 613 - 619
  • [45] Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis
    He, Chaobin
    Wang, Jun
    Sun, Shuxin
    Zhang, Yu
    Lin, Xiaojun
    Lao, Xiangming
    Cui, Bokang
    Li, Shengping
    BMC CANCER, 2019, 19 (1)
  • [46] Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis
    Ohnuma, Hiroyuki
    Sato, Yasushi
    Onoyama, Naoki
    Hamaguchi, Kota
    Hayasaka, Naotaka
    Sato, Masanori
    Murase, Kazuyuki
    Takada, Kohichi
    Miyanishi, Koji
    Murakami, Takeshi
    Ito, Tatsuya
    Nobuoka, Takayuki
    Takemasa, Ichiro
    Kato, Junji
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (08) : 2385 - 2396
  • [47] Neoadjuvant Chemotherapy versus Surgery Alone for Locally Advanced Gastric Cancer: A Retrospective Comparative Study
    Wang, Lin Bo
    Shen, Jian Guo
    Xu, Chao Yang
    Chen, Wen Jun
    Song, Xiang Yang
    Yuan, Xiao Ming
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1895 - 1898
  • [48] Patients Administered Neoadjuvant Chemotherapy Could be Enrolled into an Enhanced Recovery after Surgery Program for Locally Advanced Gastric Cancer
    Zhao, Jian
    Wang, Gang
    Jiang, Zhi-Wei
    Jiang, Chuan-Wei
    Liu, Jiang
    Xia, Can-Can
    Li, Jie-Shou
    CHINESE MEDICAL JOURNAL, 2018, 131 (04) : 413 - 419
  • [49] Short- and long-term outcomes of laparoscopic versus open gastrectomy for locally advanced gastric cancer following neoadjuvant chemotherapy
    Fujisaki, Muneharu
    Mitsumori, Norio
    Shinohara, Toshihiko
    Takahashi, Naoto
    Aoki, Hiroaki
    Nyumura, Yuya
    Kitazawa, Seizo
    Yanaga, Katsuhiko
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2021, 35 (04): : 1682 - 1690
  • [50] Comparison of Treatment Modalities for Locally Advanced Gastric Cancer: A Propensity Score Matching Analysis
    Han, Jianglong
    Nie, Zhihua
    Li, Ping
    Shi, Hongwei
    Wang, Shijie
    Li, Qin
    Zhang, Rui
    Qiao, Yunfeng
    Huang, Kejie
    Fu, Zhenming
    JOURNAL OF CANCER, 2020, 11 (15): : 4421 - 4430